Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01516125 · ClinicalTrials.gov registry record
Screening of Healthy Adults for Genetic Variations That Control Fatty Acid Processing
A clinical trial of Healthy, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 458
- Enrollment target
- 1
- Study location
NCT01516125: Completed study of Healthy, sponsored by Wake Forest University Health Sciences.
NCT01516125 is a study of Healthy that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 458 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (29% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01516125, a study of Healthy, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 458 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to screen healthy African American and Caucasian persons for specific differences in genes that control how fats are processed in the body.
Conditions Studied
Study Locations (1)
North Carolina
- Wake Forest Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 458 participants |
| Start Date | 2011-09 |
| Est. Completion | 2019-04-17 |
What the finished NCT01516125 record still lists
NCT01516125 is an observational study that tracks outcomes without assigning an intervention. The registered 458 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (29% lower).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 0 interventions.
NCT01516125 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT01516125 about?
NCT01516125 is a clinical study titled "Screening of Healthy Adults for Genetic Variations That Control Fatty Acid Processing". The purpose of this research study is to screen healthy African American and Caucasian persons for specific differences in genes that control how fats are processed in the body.
What is the current status of trial NCT01516125?
This trial is currently completed. The enrollment target is 458 participants. The study started on 2011-09. Estimated completion is 2019-04-17.
What conditions does trial NCT01516125 study?
This clinical trial studies the following conditions: Healthy.
Who is sponsoring clinical trial NCT01516125?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01516125 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01516125's enrollment target sits among peer trials
458 54th of 1090 higher than 1,037 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05856942 · 458 participants · NA
Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program
- NCT06201676 · 458 participants · Phase 4
Low-Dose Short-Term Ketorolac to Reduce Chronic Opioid Use in Orthopaedic Polytrauma Patients
- NCT04452825 · 459 participants · NA
A New Psychotherapy Intervention for Older Cancer Patients
- NCT02977780 · 460 participants · Phase 2
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia